PITTSBURGH, Pa., November 5, 2013 – Douglas Laboratories®, the trusted choice of healthcare professionals for superior quality, science-based nutritional supplements for more than 50 years, is proud to offer customers its newest product; Cysto Renew™ Bladder Support. Formulated by Dr. Geo Espinosa, and Douglas Laboratories, Cysto Renew™ introduces bladder support as a new product category to the Douglas Laboratories® line of nutritional supplements.
“The addition of Cysto Renew™ Bladder Support formula has been an important step in continuing to offer our customers a comprehensive line to support overall health and is the first product offered in our supplement line for bladder integrity and healthy function,” said Andrew Halpner Ph.D., Vice President, Product Development and Technical Services at Douglas Laboratories.
“My work in naturopathic urology complemented Douglas Labs’s expertise in nutritional supplement formulation as we worked together to develop this new product that will help promote a calm bladder and normal urine frequency†,” said Geo Espinosa, N.D., L.Ac., C.N.S. “Each ingredient contributes to the health of the bladder glycosaminoglycan layer, nitric oxide production, healthy neuroendocrine system, and normal mast cell production that is important for a healthy functioning bladder.†”
Cysto Renew™ Bladder Support formula includes a unique blend of four clinically studied ingredients that individually contribute to the health of the bladder†:
- Chondroitin sulfate and aloe vera support the bladder glycosaminoglycan layer for healthy bladder integrity†
- Quercetin and bromelain help support normal mast cell production†
- L-Arginine and L-Citrulline contribute to nitric oxide production for muscle relaxation†
- Rhodiola rosea supports a normal stress response†
On July 24th, 2013 and September 5,2013, Douglas Laboratories hosted an educational webinar for healthcare professionals, presented by Geo Espinosa, N.D., L.Ac., C.N.S., addressing natural approaches to promoting bladder function. To view the presentation, please follow the link here.
For further information on Cysto Renew™ Bladder Support visit douglaslabs.com.
† These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease.
ABOUT DOUGLAS LABORATORIES®
A business unit of Atrium Innovations Inc. [TSX: ATB], Douglas Laboratories®, the trusted choice of thousands of healthcare professionals for over 50 years, is at the forefront of the nutritional health industry, proudly researching, developing and manufacturing superior quality, science-based supplements that help people improve their health. Douglas Laboratories provides added insurance of multiple domestic and international GMP certifications, including ISO-9001 Certification and ISO-17025 Accreditation for in-house laboratories, as well as NSF International Registration. Douglas Laboratories currently offers over 600 branded products. Douglas Laboratories distributes worldwide, with its headquarters located in Pittsburgh, Pennsylvania, USA. For additional information, please visit www.douglaslabs.com.
ABOUT DR. GEO ESPINOSA
Dr. Espinosa is a renowned naturopathic urologist, master formulator of urologic dietary supplements and an recognized authority in integrative treatments for urologic conditions, prostate cancer and interstitial cystitis / painful bladder syndrome. Dr. Geo, as he is known, is the founder and director of the Integrative Urology Center, a center of excellence in research and integrative treatments for urologic conditions. He is the co-founder and medical director of XY wellness, LLC, and the formulator of Cysto Renew™, ProstP10x™ and XY VGR™. Dr. Geo writes frequently for medical journals, academic book chapters, Prostate.net and his popular blog DrGeo.com. In his spare time he enjoys playing sports and having fun with his 3 kids.
ABOUT ATRIUM INNOVATIONS
Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available atwww.atrium-innovations.com.
